<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Jordan PM</submitter><funding>Deutsche Forschungsgemeinschaft</funding><funding>Interdisziplinäres Zentrum für Klinische Forschung, Universitätsklinikum Jena</funding><pagination>541-554</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8517600</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>164(3)</volume><pubmed_abstract>IL-33 and ATP are alarmins, which are released upon damage of cellular barriers or are actively secreted upon cell stress. Due to high-density expression of the IL-33 receptor T1/ST2 (IL-33R), and the ATP receptor P2X7, mast cells (MCs) are one of the first highly sensitive sentinels recognizing released IL-33 or ATP in damaged peripheral tissues. Whereas IL-33 induces the MyD88-dependent activation of the TAK1-IKK2-NF-κB signalling, ATP induces the Ca&lt;sup>2+&lt;/sup> -dependent activation of NFAT. Thereby, each signal alone only induces a moderate production of pro-inflammatory cytokines and lipid mediators (LMs). However, MCs, which simultaneously sense (co-sensing) IL-33 and ATP, display an enhanced and prolonged activation of the TAK1-IKK2-NF-κB signalling pathway. This resulted in a mass</pubmed_abstract><journal>Immunology</journal><pubmed_title>ATP/IL-33-triggered hyperactivation of mast cells results in an amplified production of pro-inflammatory cytokines and eicosanoids.</pubmed_title><pmcid>PMC8517600</pmcid><funding_grant_id>DFG DR1113/1-1</funding_grant_id><funding_grant_id>CRC854/A28N</funding_grant_id><funding_grant_id>316213987</funding_grant_id><funding_grant_id>SFB1278/1</funding_grant_id><funding_grant_id>IZKF-MSP-1</funding_grant_id><funding_grant_id>DFG DR1113/1‐1</funding_grant_id><funding_grant_id>RTG 2408/TP4</funding_grant_id><pubmed_authors>Groth M</pubmed_authors><pubmed_authors>Dudeck A</pubmed_authors><pubmed_authors>Drube S</pubmed_authors><pubmed_authors>Kuchler C</pubmed_authors><pubmed_authors>Serfling E</pubmed_authors><pubmed_authors>Jordan PM</pubmed_authors><pubmed_authors>Weber F</pubmed_authors><pubmed_authors>Andreas N</pubmed_authors><pubmed_authors>Jager U</pubmed_authors><pubmed_authors>Wegner P</pubmed_authors><pubmed_authors>Kamradt T</pubmed_authors><pubmed_authors>Werz O</pubmed_authors></additional><is_claimable>false</is_claimable><name>ATP/IL-33-triggered hyperactivation of mast cells results in an amplified production of pro-inflammatory cytokines and eicosanoids.</name><description>IL-33 and ATP are alarmins, which are released upon damage of cellular barriers or are actively secreted upon cell stress. Due to high-density expression of the IL-33 receptor T1/ST2 (IL-33R), and the ATP receptor P2X7, mast cells (MCs) are one of the first highly sensitive sentinels recognizing released IL-33 or ATP in damaged peripheral tissues. Whereas IL-33 induces the MyD88-dependent activation of the TAK1-IKK2-NF-κB signalling, ATP induces the Ca&lt;sup>2+&lt;/sup> -dependent activation of NFAT. Thereby, each signal alone only induces a moderate production of pro-inflammatory cytokines and lipid mediators (LMs). However, MCs, which simultaneously sense (co-sensing) IL-33 and ATP, display an enhanced and prolonged activation of the TAK1-IKK2-NF-κB signalling pathway. This resulted in a mass</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Nov</publication><modification>2025-04-22T11:27:09.355Z</modification><creation>2025-04-06T00:01:09.754Z</creation></dates><accession>S-EPMC8517600</accession><cross_references><pubmed>34142370</pubmed><doi>10.1111/imm.13386</doi></cross_references></HashMap>